Price T Rowe Associates Inc Vera Therapeutics, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,393,029 shares of VERA stock, worth $86.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,393,029Holding current value
$86.6 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
173Shares Held
52.7MCall Options Held
117KPut Options Held
290K-
Avoro Capital Advisors LLC New York, NY5.27MShares$190 Million2.74% of portfolio
-
Black Rock Inc. New York, NY3.32MShares$120 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.17MShares$115 Million11.79% of portfolio
-
Abingworth LLP London, X02.96MShares$107 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$101 Million7.01% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $978M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...